Hutchinson Center to lead $11.5 million ovarian-cancer research consortium

rofessor, UW Department of Biostatistics.

Project 5: Improving quality of life for women with ovarian cancer - Can facilitated group counseling improve patients' quality of life, postpone cancer recurrence and increase survival time? This project aims to find out through a randomized controlled trial of women who undergo group counseling. Consortium researchers will work closely with local advocates (ovarian-cancer survivors) to ensure that the intervention is sensitive to the real needs of women with advanced ovarian cancer. If group counseling is found to significantly improve outcomes, it can be adopted immediately and incorporated in standard care. Already there is some evidence, from previous smaller studies, that social support can improve survival among cancer patients. For example, one study indicates that group counseling improved survival of women with advanced breast cancer from 18 months to 36 months. Project leader: M. Robyn Andersen, Ph.D., an assistant member of the Cancer Prevention Research Program within the Hutchinson Center's Public Health Sciences Division. Because ovarian cancer is relatively rare, it is particularly important that every patient diagnosed with the disease be included in the pool of potential participants for SPORE research. The project's Clinical Core will accomplish this objective by coordinating recruitment of both ovarian-cancer patients and at-risk women among Consortium patient-care facilities, and by recruiting additional facilities to participate in SPORE research. The Clinical Core will be headed by principal investigator Charles Drescher, M.D., an affiliate investigator in the Hutchinson Center's Public Health Sciences Division. In addition to mobilizing recruitment efforts, the Clinical Core also will interact with physicians and health-care providers in Washington state to translate the Consortium's research findings back to the community. "The Clinical

Contact: Kristen Woodward
Fred Hutchinson Cancer Research Center

Page: 1 2 3 4 5 6

Related biology news :

1. Intel and Fred Hutchinson to explore the use of nanotechnology tools for early disease detection
2. American Association for Cancer Research honors Fred Hutchinson Cancer Research Center investigator
3. Fred Hutchinson Cancer Research Center, University of Washington join in national effort to study health impact of toxic substances
4. Hutchinson Center researchers first to induce state of suspended animation in model vertebrate organism
5. Digging for genetic fossils: Hutchinson Center researchers solve structure of ancient biological molecule
6. Fred Hutchinson Cancer Research Center to lead international team to accelerate investigation of immune-related genes
7. Hutchinson Center researcher awarded Block lectureship
8. White House honors Hutchinson Center Scientist with Presidential Early Career Award
9. Fred Hutchinson Cancer Research Center researcher one of five awarded $1 million distinguished young scholars grant
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Hutchinson Center Director Wins Americas Nobel

Post Your Comments:

(Date:7/18/2020)... TORONTO (PRWEB) , ... July 17, 2020 , ... Commercial ... hangs on pharma’s ability to discover a COVID cure or vaccine, the global economic ... competitive and price pressure is not going away and capturing full value from every ...
(Date:7/4/2020)... (PRWEB) , ... July 03, 2020 , ... ... proud to earn outstanding recognition and multiple awards for not only the products ... ABM portfolio, SoME® Skincare and Vivace® Microneedle RF. All the brands built by ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, ... the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga ... supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... In most ... used to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate ... Dr MA has been using the zebrafish model to investigate the causes of ...
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... announced that the launch of a new clinical diagnostics immuno-oncology service, ... tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
Breaking Biology Technology:
Cached News: